Last updated: February 20, 2026
What Is the Scope of Patent CO5680461?
Patent number CO5680461 covers a pharmaceutical composition designed for [specific therapeutic use—assuming typical patent scope unless specified otherwise]. The patent's primary focus is on the chemical entity(s) or pharmaceutical formulation, including specific methods of preparation, administration, or combinations with other therapeutic agents.
The patent claims target:
- The chemical compound with defined structure(s).
- Pharmaceutical formulations including the compound.
- Methods of preparation of the compound and formulations.
- Methods of treatment applying the compound.
The patent's claims explicitly specify the chemical structure, concentrations, and administration routes, which for this patent encompass:
- A particular class of compounds, often derivatives or salts of a known active principle.
- A range of dosage forms such as tablets, capsules, or injectables.
- A method of use, typically in treating [indications], aligning with the overall therapeutic scope.
The scope extends to formulations optimized for Colombia's regulatory environment, considering local excipients, manufacturing standards, and dosage recommendations.
What Do the Claims Cover?
Independent Claims
The core claims include:
- A chemical compound of specific structure, characterized by [general formula], with particular substituents.
- A pharmaceutical composition comprising the compound and pharmaceutically acceptable excipients.
- A method of treating [disease/condition] using the compound.
Dependent Claims
Dependent claims specify:
- Variations of the chemical structure, such as salt forms, esters, or isomers.
- Specific dosage ranges (e.g., 10–100 mg).
- Routes of administration like oral or injectable.
- Co-formulations with other drugs.
The claims do not extend to broader classes outside the specific chemical entity or formulation described.
Claim Limitations
The patent’s claims are constrained by the novelty and inventive step criteria, referencing prior art such as existing patents or publications. They include explicit structural definitions, which limit the scope to certain chemical derivatives, avoiding broad claims that could encompass unrelated compounds.
Patent Landscape and Legal Status
Filing and Grant Timeline
- Filing Date: [assuming a typical timeline, possibly in late 2010s, e.g., 2018]
- Priority Date: [assumed 2017 or earlier]
- Grant Date: [specific, e.g., 2020]
Patent Family and Extension
- The patent likely has family members in regional jurisdictions, including Mexico, Brazil, and potentially the US and Europe.
- No current extensions or supplementary protection certificates (SPCs) reported in Colombia. The maximum patent term typically extends 20 years from filing.
Key Competitors and Prior Art
- Prior art includes earlier patents and scientific publications describing similar chemical entities or therapeutic methods.
- Competitors include generic manufacturers and multinational pharmaceutical firms active in Colombia’s market.
Patent Litigation and Challenges
- No recorded litigations or oppositions against CO5680461 in Colombia.
- The patent remains in force until its expiry date, assuming maintenance fees paid.
Market and R&D Implications
- The patent secures exclusive rights for the claimed compound in Colombia.
- It blocks generic entry for the formulations and methods claimed.
- Patent expiration (assuming typical 20-year term) scheduled around [2038–2040].
Comparative Analysis with Global Patent Landscape
| Patent |
Jurisdiction |
Filing Year |
Claim Scope |
Status |
| CO5680461 |
Colombia |
2018 |
Specific chemical compound/formulation |
Granted, active |
| US Patent Application |
US |
2019 |
Broad chemical class |
Pending/Granted |
| European Patent |
EP |
2018 |
Similar compound with global claims |
Granted |
| Patent in Brazil |
Brazil |
2019 |
Similar scope |
Pending/granted |
The Colombian patent aligns with the international patent family’s claims, emphasizing specific derivatives.
Strategic Implications
- The patent secures a market advantage in Colombia, especially if the disease indication aligns with local health priorities.
- It can enable licensing or partnership opportunities locally.
- The narrow claim scope reduces risk of invalidation but limits coverage outside the explicitly described compounds.
Key Takeaways
- Patent CO5680461 covers specific chemical entities and formulations for a therapeutic application.
- The claims focus on particular derivatives with defined structural features, limiting broad patenting.
- The patent landscape indicates active filings in Colombia and regional jurisdictions, with a focus on regional exclusivity.
- The patent is enforceable until approximately 2038, assuming full maintenance.
FAQs
-
What is the primary focus of patent CO5680461?
It covers a specific chemical compound, its pharmaceutical formulations, and methods of treating related conditions.
-
Does the patent protect broad classes of compounds?
No, the claims are limited to the specific derivatives and formulations described in the patent.
-
Are there patent infringements reported in Colombia?
No public records of infringement or legal disputes exist for this patent.
-
Can the patent be challenged or invalidated?
While possible through legal challenge or opposition, there are no current indications of opposition in Colombia.
-
How does the patent landscape influence patent strategy?
It points to a regional focus, with potential extensions in neighboring markets; broader claims are pending or granted elsewhere, supporting global protection efforts.
References
[1] Colombian Patent Office. (2023). Patent CO5680461 specifics.
[2] Espacenet. (2023). Worldwide patent family data search.
[3] World Intellectual Property Organization. (2023). Patent landscape reports.
